A Multi-Center Study of [−2]Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/mL PSA Range

PURPOSE: PSA and free PSA (fPSA) have limited specificity for detecting clinically significant, curable prostate cancer (PCa), leading to unnecessary biopsies and detection and treatment of some indolent tumors. [−2]proPSA (p2PSA) may improve specificity for detecting clinically significant PCa. Our...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Catalona, William J., Partin, Alan W., Sanda, Martin G., Wei, John T., Klee, George G., Bangma, Chris H., Slawin, Kevin M., Marks, Leonard S., Loeb, Stacy, Broyles, Dennis L., Shin, Sanghyuk S., Cruz, Amabelle B., Chan, Daniel W., Sokoll, Lori J., Roberts, William L., van Schaik, Ron H.N., Mizrahi, Isaac A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140702/
https://ncbi.nlm.nih.gov/pubmed/21419439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.12.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados